COMPARISON OF OUTCOMES OF SINGLE CORD BLOOD TRANSPLANTATION AND HLA 1-3 ANTIGEN-MISMATCHED RELATED STEM CELL TRANSPLANTATION USING LOW-DOSE ANTITHYMOCYTE GLOBULIN FOR HEMATOLOGICAL MALIGNANCIES

EHA Library, Fumiya Wada, 324949

OUTCOMES FOLLOWING UNMANIPULATED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AMONG 111 MIXED-PHENOTYPE ACUTE LEUKEMIA PATIENTS AT A SINGLE CENTER

EHA Library, Yan-Li Zhao, 324950

CURRENT ROLE OF ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) IN MANTLE CELL LYMPHOMA (MCL) IN THE ERA OF NEW IMMUNOTHERAPEUTIC AND TARGETED THERAPIES. THE GETH/GELTAMO EXPERIENCE.

EHA Library, Antonio Gutiérrez, 324951

DYNAMIC ASSESSMENT OF PERIPHERAL PERFUSION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION SURVIVORS

EHA Library, Eleni Gavriilaki, 324952

DAY 0 EASIX SCORE MIGHT PREDICT OVERALL SURVIVAL AND TRANSPLANT RELATED MORTALITY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE.

EHA Library, Elisabetta Metafuni, 324953

EARLY-ONSET CYTOKINE RELEASE SYNDROME FOLLOWING ALLOGENEIC HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION MIGHT DECREASE OVERALL SURVIVAL

EHA Library, Alberto Hernandez-Sanchez, 324954

TRIAL OF AB-205 (E-CEL® CELLS) IN ADULTS WITH SYSTEMIC LYMPHOMA UNDERGOING HIGH-DOSE THERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (HDT-AHCT)RESULTS OF AB-205-001 BY AGE SUBGROUP

EHA Library, Mehrdad Abedi, 324955

DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND MORTALITY OF ADULT HEMATOLOGICAL CANCER PATIENTS WITH VENO-OCCLUSIVE DISEASE IN ENGLAND, 2010 TO 2020

EHA Library, Indraraj Umesh Doobaree, 324956

PHASE II CLINICAL TRIAL (EMN-ALLORIC 2010) OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR HIGH RISK (HR) MULTIPLE MYELOMA (MM) FOLLOWED BY MAINTENANCE WITH BORTEZOMIB AND LENALIDOMIDE. UPDATED ANALYSIS.

EHA Library, Marta Reinoso Segura, 324957

LATE-ONSET VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) AFTER HEMATOPOIETIC CELL TRANSPLANTATION (HCT): OUTCOMES OF DEFIBROTIDE-TREATED PATIENTS FROM THE EBMT PASS REGISTRY STUDY

EHA Library, James Angus, 324958

OPTIMOB STUDY: INTERIM ANALYSIS OF THIS NON-INTERVENTIONAL TRIAL IN GERMANY TO EVALUATE THE MOBILIZATION AND COLLECTION OF HEMATOPOIETIC STEM CELLS IN POOR MOBILIZERS

EHA Library, Christian Kunz, 324959

CO-REACTIVATION OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUS WAS ASSOCIATED WITH POOR PROGNOSIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Jing-Rui Zhou, 324960

IMPACT OF IMMUNE STATUS ON HOSPITAL READMISSION AFTER ALLO-HSCT

EHA Library, Irina Galtseva, 324961

ASSOCIATION OF TRAVEL TIME TO TRANSPLANT CENTER AND POST-TRANSPLANT CARE MODEL WITH OUTCOME PARAMETERS AFTER ALLOGENEIC TRANSPLANTATION

EHA Library, Raffaele Peter, 324962

THE ADDITION OF ATG TO NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION WITH FLUDARABINE AND CYCLOPHOSPHAMIDE REDUCES GVHD AT THE EXPENSE OF HIGHER RELAPSE RATES AND POORER OVERALL SURVIVAL.

EHA Library, Mayani Rawicki, 324963

EVALUATION OF SOLUBL HLA-G AND CYTOKINE LEVELS IN CHILDREN WITH ACUTE LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Zéhre Kaya, 324964

SUBMYELOABLATIVE TBI-BASED CONDITIONING AND ALLOGENEIC HEMATOPOETIC CELL TRANSPLANTATION IN HIGH-RISK MYELOMA WITH EARLY PROGRESSION POST AUTOLOGOUS TRANSPLANTATION

EHA Library, Elias K. Mai, 324965

G-CSF-PRIMED PERIPHERAL BLOOD STEM CELL HAPLOIDENTICAL TRANSPLANTATION COULD ACHIEVE SATISFACTORY CLINICAL OUTCOMES FOR ACUTE LEUKEMIA PATIENTS IN THE FIRST COMPLETE REMISSION: A REGISTERED STUDY

EHA Library, Yanru Ma, 324966

MAINTENANCE THERAPY AFTER ALLOGENEIC HEMATOPOIETIC TRANSPLANT FOR ACUTE MYELOID LEUKEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Oren Pasvolsky, 324967

OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR AML PATIENTS WITH 11P15/NUP98 REARRANGEMENT

EHA Library, Shu Yan, 324968

EFFECT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION(HSCT)IN SEVERE CONGENITAL NEUTROPENIA

EHA Library, Min Xiong, 324969

OUTPATIENT PROGRAM BASED ON TELEMEDICINE IS A GOOD OPTION TO MANAGE PRE-ENGRAFTMENT PHASE IN MYELOMA MULTIPLE PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Pedro Gonzalez-Sierra, 324970

INCIDENCE OF EARLY TOXICITIES AND MORTALITY AFTER 4 TYPES OF CONDITIONING REGIMENS FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMAS: A RETROSPECTIVE ANALYSIS.

EHA Library, Jhonny Manuel Carranza Jara, 324971

DEVELOPMENT AND VALIDATION OF A RISK SCORE SYSTEM FOR SKIN AND SOFT TISSUE INFECTIONS IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS

EHA Library, Shan Chong, 324972

SECOND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE IN SALAMANCA, SPAIN.

EHA Library, Felipe Peña Muñoz, 324973

THE IMPACT OF MEASURABLE RESIDUAL DISEASE POSITIVITY BEFORE ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH PH(-) ACUTE LYMPHOBLASTIC LEUKEMIA : A SINGLE CENTER EXPERIENCE

EHA Library, Apostolia Papalexandri, 324974

PERIPHERAL BLOOD STEM CELL APHERESIS IN LOW-WEIGHT HEALTHY DONORS: A SINGLE CENTRE EXPERIENCE

EHA Library, Malek Benakli, 324975

IMPROVED SURVIVAL IN MYELOFIBROSIS PATIENTS RECEIVING RUXOLITINIB POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Eleni Gavriilaki, 324976

A MODIFIED BUSULFAN/CYCLOPHOSPHAMIDE CONDITIONING REGIMEN INCORPORATING CLADRIBINE FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Yuanyuan Shi, 324977

INCIDENCE OF VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION IN ENGLAND BASED ON HEALTHCARE RESOURCE GROUP CODES AND HOSPITAL EPISODE STATISTICS© DATA

EHA Library, James Angus, 324978

THE EFFECT OF MYELOMA INDUCTION THERAPY TYPE AND DURATION ON PERIPHERAL BLOOD STEM CELL HARVEST FOR AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Charlotte Pawlyn, 324979

ADVERSE IMPACT OF PRE-TRANSPLANT MINIMAL RESIDUAL DISEASE ON OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ACUTE LEUKEMIA PATIENTS.

EHA Library, Zoya Konova, 324980

RELATIONSHIP OF HLA ALLELES AND THE RISK OF CYTOMEGALOVIRUS (CMV) REACTIVATION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)

EHA Library, Shruti Prem, 324981

SURVIVAL AFTER SEQUENTIAL FLAMSA-BU CONDITIONING REGIMEN IS HIGHLY DEPENDENT ON PRE-HSCT MRD STATUS IN HIGH-RISK MYELOID NEOPLASM

EHA Library, Grégoire Le Meur, 324982

LETERMOVIR FOR CMV PROPHYLAXIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION - CLINICAL 'REAL WORLD' EXPERIENCE

EHA Library, Lana Desnica, 324983

THE PRELIMINARY RESULTS OF EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION FOR IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL.

EHA Library, Aleksei Koviazin, 324984

KIR2DL2/L3 SINGLE POSITIVE/NKG2C+ NK CELLS SIGNIFICANTLY EXPAND IN NKG2C+ NK CELLS DURING EDUCATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Wei Zuo, 324985

DOWN-REGULATION OF HLA EXPRESSION IN ACUTE LEUKEMIA PATIENTS RELAPSED POST TRANSPLANTATION CORRELATED WITH MRD DURATION

EHA Library, Hui Wang, 324986

DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS FROM A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Beatrice De Marco, 324987

FEASIBILITY OF ALLOGENEIC STEM-CELL TRANSPLANTATION WITH CONDITIONING REGIMEN OF 5-DAY DECITABINE IN MDS AND MDS/MPN：A MULTICENTER PROSPECTIVE COHORT STUDY IN CHINA

EHA Library, Yigeng Cao, 324988

DONOR-DERIVED ACTIVATED NK CELLS IN MANAGEMENT OF RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA

EHA Library, Zhihui Li, 324989

RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS WITH RENAL FAILURE: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Maiia Soloveva, 324990

POST-TRANSPLANTATION FLUDARABINE AND CYCLOPHOSPHAMIDE SELECTED AND PROMOTED UNRELATED UCB IMPLANTATION IN COMBINED TRANSPLANTION OF HALPOID AND UCB STEM CELLS FOR TREATMENT OF PEDIATRIC LEUKEMIA

EHA Library, Xiaoqin Feng, 324991

RELAPSED/REFRACTORY (R/R) HODGKIN LYMPHOMA (HL): WHO SHOULD RECEIVE CONSOLIDATION TREATMENT AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)? EXPERIENCE OUTSIDE CLINICAL TRIALS.

EHA Library, Dimitrios Galopoulos, 324992

AREA UNDER THE CURVE BASED MYCOPHENOLATE MOFETIL DOSAGE REDUCED THE INCIDENCE OF GVHD AFTER ALLOGENIC HSCT IN PEDIATRIC PATIENTS: ONE FACILITY'S EIGHT-YEAR EXPERIENCE

EHA Library, Antonio Grasso, 324993

EBMT, RPAM AND EASIX SCORES – IS THERE A BETTER PREDICTOR OF SURVIVAL AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA?

EHA Library, Carolina Afonso, 324994

PREVALENCE OF PURE RED CELL APLASIA AFTER HEMATOPOIETIC TRANSPLANTATION USING MAJOR ABO-INCOMPATIBLE UNMANIPULATED PERIPHERAL BLOOD STEM CELLS

EHA Library, Yi Luo, 324995

EXCELLENT COMPARABLE OUTCOMES OF HAPLO-HSCT IN HIGH RISK MYELOID MALIGNANCIES USING MYELOABLATIVE OR REDUCED INTENSITY CONDITIONING WITH LOW RISK OF CGVHD IN RECIPIENTS OF PERIPHERAL BLOOD STEM CELL

EHA Library, Daniele Avenoso, 324996

CLINICAL EXPERIENCE OF VENETOCLAX THERAPY AS A BRIDGE TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Tingting Yang, 324997

INCIDENCE, ETIOLOGY AND PROGNOSTIC IMPACT OF ATYPICAL ELECTROPHORETIC PROFILES IN PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hedhli Kaies, 324998

GOOD OUTCOME OF HIGH-RISK MYELOFIBROSIS IN ELDERLY RECIPIENTS AFTER FULL INTENSITY T-DEPLETE CONDITIONING WITH FLUDARABINE, BUSULFAN, WITH SINGLE AGENT CICLOSPORIN AS GVHD PROPHYLAXIS.

EHA Library, Daniele Avenoso, 324999

THE RELATIONSHIP BETWEEN THE CONCENTRATION OF VITAMIN A, C AND E, CYTOKINES AND THE OCCURRENCE AND SEVERITY OF MUCOSITIS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES UNDERGOING AHSCT

EHA Library, Agnieszka Szymczyk, 325000

PROGNOSTIC FACTORS AND OUTCOME OF CYTOMEGALOVIRUS INFECTION IN POST-ALLOGENEIC STEM CELL RECIPIENTS. FIVE YEARS RETROSPECTIVE STUDY.

EHA Library, José Quintela, 325001

THE IMPACT OF HEMATOPOIETIC STEM CELLS QUANTITY AND QUALITY ON HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS OR ALLOGENIC GRAFT: A TWO YEARS MULTICENTRIC RETROSPECTIVE STUDY

EHA Library, Caroline De Oliveira, 325002

THE DURATION OF ANTIBIOTICS WITH DIFFERENT SPECTRUMS ADMINISTERED DURING ALLOGENEIC HEMATOPOEITIC STEM CELL TRANSPLANTATION CAN PREDICT GVHD.

EHA Library, Meltem Kurt Yüksel, 325003

EXCELLENT ENGRAFTMENT AND LOW RELAPSE RATE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR MYELOFIBROSIS AFTER CONDITIONING WITH FLUDARABINE, TREOSULFAN AND ATG: A RETROSPECTIVE SINGLE CENTER STUDY

EHA Library, Catharina Hazenberg, 325004

THE IMPACT OF PRETRANSPLANT BODY MASS INDEX ON OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Sabrine Mekni, 325005

IMPACT OF DARATUMUMAB (DARA) ADMINISTRATION DURING TRANSPLANT- ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TE NDMM) INDUCTION ON STEM CELL (SC) MOBILIZATION COUNT AND POST-TRANSPLANT ENGRAFTMENT.

EHA Library, Edvan Crusoe, 325006

ALLOGENEIC STEM CELL TRANSPLANTATION OF PATIENTS WITH MYELOFIBROSIS AT UNIVERSITY HOSPITAL CENTRE ZAGREB FROM 2010 TO 2020

EHA Library, Radovan Vrhovac, 325007

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH TBI-BASED REDUCED INTENSITY CONDITIONING FOLLOWED BY POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR RELAPSED/REFRACTORY LYMPHOMA PATIENTS.

EHA Library, Mario Griselli, 325008

T-REPLETE HAPLOIDENTICAL STEM CELL TRANSPLANTION UTILISING POST-TRANSPLANT CYCLOPHOSPHAMIDE IS ASSOCIATED WITH INCREASED NON-RELAPSE MORTALITY IN PATIENTS OVER THE AGE OF 60

EHA Library, Heshani Mediwake, 325009

IMPACT OF FLT3 INTERNAL TANDEM DUPLICATION ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA

EHA Library, Carolina Afonso, 325010

PEDIATRIC MALES RECEIVING HEMATOPOIETIC STEM CELL TRANSPLANT SHOW AN EXTRA BENEFIT FROM THE PROCEDURE’S HORMONE IMPAIRMENT: A RETROSPECTIVE COHORT OBSERVATIONAL STUDY

EHA Library, Antonio Grasso, 325011

ALLOGENEIC STEM CELL TRANSPLANTATION FOR CUTANEOUS T-CELL LYMPHOMA

EHA Library, Daniel Angelov, 325012

HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOR PEDIATRIC PATIENTS WITH HIGH DONOR-SPECIFIC ANTIBODY (DSA) TITERS USING A DESENSITIZING CONDITIONING REGIMEN

EHA Library, Uet Yu, 325013

PD-1 INHIBITOR SIGNIFICANTLY INCREASES ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC REFRACTORY/RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yanzhi Song, 325014

HUC-MSC-EVS-ATO REDUCES ACUTE GVHD VIA RESETTING INFLAMMATORY MACROPHAGES TOWARD M2 PHENOTYPE THAT IS MEDIATED BY AUTOPHAGY

EHA Library, Yan Su, 325015

MICRORNA SERUM PROFILES AND CHRONIC GRAFT VERSUS HOST DISEASEFOR PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hakon Reikvam, 325016

TRANSCRIPTOME ANALYSIS OF HAEMATOPOIETIC STEM CELLS AFTER MOBILIZATION WITH CYTARABINE AND CYCLOPHOSPHAMIDE

EHA Library, Lucie Huvarova, 325017

EXPLOITING THE HEMATOPOIETIC SUPPORTIVE ACTIVITY OF MESENCHYMAL STROMAL CELLS TO IMPROVE THE TRANSPLANTATION OUTCOME OF GENE-EDITED HSPCS.

EHA Library, Stefania Crippa, 325018

EFFECT OF CD34+ DERIVED MICROPARTICLES ON THE CLONOGENIC POTENTIAL OF MONONUCLEAR CELLS FROM CORD BLOOD

EHA Library, Angeliki Xagorari, 325019

COSTIMULATORY MOLECULE DNAM-1 EXPRESSION ON NK CELLS IS DETERMINED BY HLA AND CORRELATED WITH NK CELL EDUCATION POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Qian-Nan Shang, 325020

INTERIM RESULTS OF BETIBEGLOGENE AUTOTEMCEL GENE THERAPY IN PEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) TREATED IN THE PHASE 3 NORTHSTAR-2 AND NORTHSTAR-3 STUDIES.

EHA Library, Andreas E. Kulozik, 325021

TFR2-HAPLOINSUFFICIENCY IMPROVES THE PHENOTYPE IN A MURINE MODEL OF TRANSFUSION-DEPENDENT Β-THALASSEMIA

EHA Library, Simona Maria Di Modica, 325022

POSSIBLE CORRELATION OF MIXED CHIMERISM WITH POST-TRANSPLANT OUTCOME IN PATIENTS WITH Β THALASSEMIA:RISK OF GRAFT FAILURE

EHA Library, Wanxia Tan, 325023

FEWER RED BLOOD CELL TRANSFUSION UNITS AND VISITS ACROSS BASELINE TRANSFUSION BURDEN LEVELS IN PATIENTS WITH BETA-THALASSEMIA TREATED WITH LUSPATERCEPT IN THE PHASE 3 BELIEVE TRIAL

EHA Library, Ali T. Taher, 325024

LONG-TERM EFFICACY AND SAFETY OUTCOMES IN THE PHASE 2 STUDY OF LUSPATERCEPT IN Β-THALASSEMIA

EHA Library, Antonio Piga, 325025

BENEFIT OF CONTINUING THERAPY WITH LUSPATERCEPT IN PATIENTS WITH BETA-THALASSEMIA WHO DO NOT ACHIEVE ≥33% REDUCTION IN RED BLOOD CELL (RBC) TRANSFUSION BURDEN (TB) IN WEEKS 13–24 IN THE BELIEVE TRIAL

EHA Library, Antonio Piga, 325026

COVID-19 PREVALENCE AND MORTALITY IN A LARGE ITALIAN HEMOGLOBINOPATHIES COHORT

EHA Library, Filomena Longo, 325027

HIGHLY EFFICIENT THERAPEUTIC GENOME EDITING OF HEMATOPOIETIC STEM AND PROGENITOR CELLS TO CURE SICKLE CELL DISEASE AND THALASSEMIA

EHA Library, Han Verhagen, 325028

A RETROSPECTIVE DATABASE STUDY OF DISEASE COURSE AND CLINICAL OUTCOMES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) IN ITALY

EHA Library, Aurelio Maggio, 325029

AUDITORY CORTEX HYPOPERFUSION: A METABOLIC HALLMARK IN BETA THALASSEMIA

EHA Library, Immacolata Tartaglione, 325030

THE VALUE OF EARLY HISTOLOGICAL FINDINGS IN PREDICTING SEVERE HEPATIC EVENTS IN Β-THALASSEMIA

EHA Library, Konstantina Koumasi, 325031

A MULTICENTER OPEN-LABEL STUDY ON THE SAFETY AND ACCEPTABILITY OF TWICE-DAILY DEFERIPRONE TABLETS AMONG PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA AND SYSTEMIC IRON OVERLOAD

EHA Library, Antonis Kattamis, 325032

PANCREATIC IRON CORRELATES WITH ALTERATIONS OF GLUCOSE METABOLISM AND CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS

EHA Library, Antonella Meloni, 325033

PROSPECTIVE COMPARISON ON PANCREATIC IRON BY MAGNETIC RESONANCE IN THALASSEMIA MAJOR PATIENTS TREATED WITH COMBINATION DEFERIPRONE–DESFERRIOXAMINE VERSUS DEFERIPRONE AND DEFERASIROX IN MONOTHERAPY

EHA Library, Antonella Meloni, 325034

QUANTIFYING THE HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES OF PATIENTS WITH BETA THALASSAEMIA IN ENGLAND

EHA Library, James Farrell, 325035

THE DATA FROM NATIONAL REGISTER FOR SURVEILLANCE OF STANDARD OF CARE IN THALASSEMIA IN TURKEY

EHA Library, Yesim Aydinok, 325036

THE PATIENTS WITH THALASSEMIA MAJOR MAY STILL DISPLAY GROWTH HORMONE DEFICIENCY DESPITE OPTIMUM TRANSFUSION AND IRON CHELATION THERAPY

EHA Library, Yesim Aydinok, 325037

GLOBAL THALASSEMIA EPIDEMIOLOGY: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Christina X. Chamberlain, 325038

DIRECT ORAL ANTICOAGULANTS FOR THE SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM: COMPARISON BETWEEN PATIENTS WITH MAJOR CONGENITAL THROMBOPHILIA AND NON-THROMBOFILIC PATIENTS

EHA Library, Alessandra Serrao, 325039

COMPARISON OF DIFFERENT CLINICAL RISK ASSESSMENT MODELS (RAMS) FOR THROMBOSIS IN AMBULATORY CANCER PATIENTS RECEIVING CHEMOTHERAPY FROM THE SECOND COHORT ONCOTHROMB 12-01 STUDY

EHA Library, Magdalena Ruiz, 325040

NON-THROMBOTIC COMPLICATIONS OF ANTIPHOSPHOLIPID SYNDROME

EHA Library, Sviatlana Khoduleva, 325041

HIGH RATE OF BLEEDING AND ARTERIAL THROMBOSIS IN COVID-19: SAUDI MULTICENTER STUDY

EHA Library, abdulrahman al raizah, 325042

PLATELET COUNT AND MEAN VOLUME IN ACUTE STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Farzaneh Sadeghi, 325043

PROGNOSTIC VALUE OF SONORRHEOMETRY IN COAGULOPATHY IN COVID-19 PATIENTS.

EHA Library, Francisco Jose Lopez Jaime , 325044

THROMBOTIC EVENTS AND THE PROFILE OF HEREDITARY THROMBOPHILIA FACTORS IN COVID-19 PATIENTS

EHA Library, Adhamjon Abdullaev, 325045

ROTATIONAL THROMBOELASTOMETRY (ROTEM) PROFILING OF COVID–19 PATIENTS

EHA Library, Nikica Sabljić, 325046

INCIDENCE OF THROMBOHAEMORRHAGIC COMPLICATIONS IN THE PERIPROCEDURAL OF ORAL ANTICOAGULANT TREATMENT WITH VITAMIN K ANTAGONISTS

EHA Library, María Argüello, 325047

PLATELET ADHESION, VON WILLEBRAND FACTOR ACTIVATION AND LEUKOCYTES RECRUITMENT AT HIGH SHEAR RATES

EHA Library, Yuliya Avtaeva, 325048